STAT3 signaling and the hyper-IgE syndrome

被引：36

作者：

Levy, David E. ^{[1
]}

Loomis, Cynthia A. ^{[1
]}

机构：

[1] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 357卷 / 16期

关键词：

D O I：

10.1056/NEJMe078197

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1655 / 1658

页数：4

共 16 条

[1] Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer - Modern target but ancient solution [J].

Aggarwal, Bharat B. ;

Sethi, Gautam ;

Ahn, Kwang Seok ;

Sandur, Santosh K. ;

Pandey, Manoj K. ;

Kunnumakkara, Ajaikumar B. ;

Sung, Bokyung ;

Ichikawa, Haruyo .

SIGNAL TRANSDUCTION PATHWAYS, PT B: STRESS SIGNALING AND TRANSCRIPTIONAL CONTROL, 2006, 1091 :151-169

[2] Th17: the third member of the effector T cell trilogy [J].

Bettelli, Estelle ;

Korn, Thomas ;

Kuchroo, Vijay K. .

CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (06) :652-657

[3] Inborn errors of IL-12/23- and IFN-γ-mediated immunity:: Molecular, cellular, and clinical features (vol 18, pg 347, 2006) [J].

Filipe-Santos, Orchidee ;

Bustamante, Jacinta ;

Chapgier, Ariane ;

Vogt, Guillaume ;

de Beaucoudrey, Ludovic ;

Feinberg, Jacqueline ;

Jouanguy, Emmanuelle ;

Boisson-Dupuis, Stphanie ;

Fieschi, Claire ;

Picard, Capucine ;

Casanova, Jean-Laurent .

SEMINARS IN IMMUNOLOGY, 2007, 19 (02) :136-137

[4] Inborn errors of IL-12/23- and IFN-γ-mediated immunity:: molecular, cellular, and clinical features [J].

Filipe-Santos, Orchidee ;

Bustamante, Jacinta ;

Chapgier, Ariane ;

Vogt, Guillaume ;

de Beaucoudrey, Ludovic ;

Feinberg, Jacqueline ;

Jouanguy, Emmanuelle ;

Boisson-Dupuis, Stephanie ;

Fieschi, Claire ;

Picard, Capucine ;

Casanova, Jean-Laurent .

SEMINARS IN IMMUNOLOGY, 2006, 18 (06) :347-361

[5] STAT3 mutations in the hyper-IgE syndrome [J].

Holland, Steven M. ;

Deleo, Frank R. ;

Elloumi, Houda Z. ;

Hsu, Amy P. ;

Uzel, Gulbu ;

Brodsky, Nina ;

Freeman, Alexandra F. ;

Demidowich, Andrew ;

Davis, Joie ;

Turner, Maria L. ;

Anderson, Victoria L. ;

Darnell, Dirk N. ;

Welch, Pamela A. ;

Kuhns, Douglas B. ;

Frucht, David M. ;

Malech, Harry L. ;

Gallin, John I. ;

Kobayashi, Scott D. ;

Whitney, Adeline R. ;

Voyich, Jovanka M. ;

Musser, James M. ;

Woellner, Cristina ;

Schaeffer, Alejandro A. ;

Puck, Jennifer M. ;

Grimbacher, Bodo .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16) :1608-1619

[6] New and old functions of STAT3 - A pivotal target for individualized treatment of cancer [J].

Inghirami, G ;

Chiarle, R ;

Simmons, WJ ;

Piva, R ;

Schlessinger, K ;

Levy, DE .

CELL CYCLE, 2005, 4 (09) :1131-1133

[7] Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth [J].

Leong, PL ;

Andrews, GA ;

Johnson, DE ;

Dyer, KF ;

Xi, SC ;

Mai, JC ;

Robbins, PD ;

Gadiparthi, S ;

Burke, NA ;

Watkins, SF ;

Grandis, JR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4138-4143

[8] STATs: Transcriptional control and biological impact [J].

Levy, DE ;

Darnell, JE .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (09) :651-662

[9] What does Stat3 do? [J].

Levy, DE ;

Lee, CK .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) :1143-1148

[10] Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome [J].

Minegishi, Yoshiyuki ;

Saito, Masako ;

Tsuchiya, Shigeru ;

Tsuge, Ikuya ;

Takada, Hidetoshi ;

Hara, Toshiro ;

Kawamura, Nobuaki ;

Ariga, Tadashi ;

Pasic, Srdjan ;

Stojkovic, Oliver ;

Metin, Ayse ;

Karasuyama, Hajime .

NATURE, 2007, 448 (7157) :1058-U10

← 1 2 →